Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Biological Sciences

2-1-2018

Aromatic interactions at the ligand–protein interface: Implications
for the development of docking scoring functions
Michal Brylinski
Louisiana State University

Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs

Recommended Citation
Brylinski, M. (2018). Aromatic interactions at the ligand–protein interface: Implications for the
development of docking scoring functions. Chemical Biology and Drug Design, 91 (2), 380-390.
https://doi.org/10.1111/cbdd.13084

This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital
Commons. For more information, please contact ir@lsu.edu.

Received: 27 May 2017
DOI: 10.1111/cbdd.13084

|

Revised: 29 June 2017

|

Accepted: 11 August 2017

RESEARCH ARTICLE

Aromatic interactions at the ligand–protein interface:
Implications for the development of docking scoring functions
Michal Brylinski1,2
1

Department of Biological Sciences,
Louisiana State University, Baton Rouge,
LA, USA

2

Center for Computation & Technology,
Louisiana State University, Baton Rouge,
LA, USA
Correspondence
Michal Brylinski, Department of Biological
Sciences, Louisiana State University, Baton
Rouge, LA, USA.
Email: michal@brylinski.org
Funding information
National Institute of General Medical
Sciences, Grant/Award Number:
R35GM119524

The ability to design and fine-tune non-covalent interactions between organic l igands
and proteins is indispensable to rational drug development. Aromatic stacking has
long been recognized as one of the key constituents of ligand–protein interfaces. In
this communication, we employ a two-parameter geometric model to conduct a
large-scale statistical analysis of aromatic contacts in the experimental and computer-
generated structures of ligand–protein complexes, considering various combinations
of aromatic amino acid residues and ligand rings. The geometry of interfacial π–π
stacking in crystal structures accords with experimental and theoretical data collected for simple systems, such as the benzene dimer. Many contemporary ligand
docking programs implicitly treat aromatic stacking with van der Waals and
Coulombic potentials. Although this approach generally provides a sufficient specificity to model aromatic interactions, the geometry of π–π contacts in high-scoring
docking conformations could still be improved. The comprehensive analysis of aromatic geometries at ligand–protein interfaces lies the foundation for the development
of type-specific statistical potentials to more accurately describe aromatic interactions in molecular docking. A Perl script to detect and calculate the geometric parameters of aromatic interactions in ligand–protein complexes is available at https://
github.com/michal-brylinski/earomatic. The dataset comprising experimental complex structures and computer-generated models is available at https://osf.io/rztha/.
KEYWORDS
π–π interactions, aromatic interactions, ligand binding, ligand docking, molecular docking, molecular
modeling, non-covalent interactions, parallel stacking, perpendicular stacking, protein–ligand complexes

1

|

IN TRO D U C T ION

Low molecular weight ligands, such as endogenous compounds and synthetic drugs, reversibly bind to proteins by
forming multiple non-covalent interactions predominantly
with the side chains of binding pocket residues. In contrast
to strong covalent bonds, these rather weak intermolecular
contacts comprise a variety of interactions that do not involve sharing electrons. Key interactions between ligands
and macromolecules include hydrogen bonds,[1,2] π–π aromatic stacking,[3,4] cation–π interactions,[5,6] hydrophobic effects,[7,8] halogen bonds,[9,10] and salt bridges.[11,12]
380
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A significant effort is directed to study the geometrical
properties and energetics of these non-covalent bonds because of their paramount importance in molecular recognition and practical applications in drug discovery.[8,13,14]
Pharmacology exploits the fact that bioactive compounds
have a sufficient specificity and potency to bind and modulate the function of macromolecular targets. At the outset
of drug development, the selection of a molecular scaffold
requisite for binding is often followed by the optimization of
the adjoining chemical moieties non-covalently interacting
with pocket residues. Here, the goal is to maximize the affinity of a drug candidate toward the target macromolecule
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and to reduce its dissociation from the functional site. On
that account, the ability to fine-tune a network of non-
covalent interactions promoting high-affinity binding of
small molecules to their targets is critical for the success of
rational drug discovery.
Two distinct, yet complementary computational techniques are used to gain insights into the structure and energy
landscape of non-covalent interactions in biological systems.
The first approach employs quantum mechanical (QM) calculations, sometimes in combination with molecular mechanics (MM). For instance, the geometrical preferences of
various types of hydrogen bonds frequently present at ligand–
protein interfaces have been investigated with QM.[15] The
derived distance and angle values describing the geometry
of hydrogen bonds can subsequently be utilized by empirical
methods to effectively model hydrogen bonds upon ligand
binding. Another study employed a hybrid QM/MM method
to analyze polarization effects playing a significant role in
the determination of ligand–protein complex structures.[16] In
this approach, fixed charges on ligand atoms obtained from
force field parameterization are replaced by those calculated
by QM/MM to improve the accuracy of the modeling of molecular assemblies. Finally, the relative strength of π–π and
cation–π interactions was investigated as a function of the geometry and protonation state in histidine-aromatic complexes
with quantum chemistry methods.[17] In addition to important
differences in the stability of aromatic interactions in the gas
phase, water, and protein-like environments, it was found that
π–π stacking is essential for the favorable electron correlation, whereas cation–π contacts produce further electrostatic
contributions. The advantage of QM methods is that these
calculations can be applied to a variety of systems and the
results obtained for idealized molecules are usually straightforward to interpret. Nonetheless, because of limits on the
system size as well as the fact that only simple molecules
in vacuum are subject to QM calculations, the derived geometric and energy parameters may not be suitable to reliably
model a biological system with its highly complex and heterogeneous environment.
On that account, another computational approach to
explore the geometry and energy landscape of various non-
covalent interactions at ligand–protein interfaces builds on
the accumulated knowledge of the atomic structures of molecular assemblies. For example, accurate potentials of mean
force (PMF) can be derived from a large number of complexes deposited in the Protein Data Bank (PDB).[18] The
Biomolecular Ligand Energy Evaluation Protocol (BLEEP)
was developed to estimate the affinity of ligand binding from
the complex structure.[19] BLEEP considers 40 different atom
types and employs a reverse Boltzmann methodology to convert the distribution of interaction distances into energy-like
pair potential functions. As it was anticipated, these potentials
promote short-range polar contacts and hydrogen bonding,
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whereas the range of hydrophobic interactions is distinctively
longer.
Another example of an atomic PMF derived from a database of ligand–protein complexes is the Astex Statistical
Potential (ASP).[20] A unique feature of this new potential
is that it accounts for differences in the exposure of various types of protein atoms toward ligand-
binding sites.
Employing ASP in molecular docking considerably improves
the accuracy of pose prediction not only across a large validation set of ligand–protein complexes, but also for a small
testing set of pharmaceutically relevant targets. Finally, two
distance-dependent statistical scoring functions were developed using probability theory, PoseScore to identify native
ligand-binding geometries and RankScore to distinguish between binding ligands and non-binding molecules.[21] Both
potentials were derived from a set of 8,885 crystallographic
structures of ligand–protein complexes employing optimized
atomic distance thresholds and including non-native ligand
geometries. In addition to experimental structures, the performance of PoseScore and RankScore was evaluated against
computer-generated protein models with encouraging results.
Because of their remarkable accuracy, these tools can support drug development by predicting ligand–protein complex structures and helping identify potentially bioactive
compounds.
In addition to parameters for contact-based and distance-
dependent pair potentials routinely derived from interaction
statistics in the PDB, this large collection of molecular structures can also be used to parameterize other types of potential functions. For instance, a sophisticated descriptor-based
scoring function integrating evolutionary constraints with
physics-based energy terms implemented in the geauxdock
docking program[22,23] was parameterized against a representative snapshot of ligand–protein complexes extracted from
the PDB. Scoring terms in geauxdock include electrostatic
and van der Waals interactions, hydrogen bonds, hydrophobic
interactions, generic and pocket-specific contact potentials, a
pseudo-pharmacophore potential, and position restraints on
family conserved anchor substructures and the binding site
center.
As an example, much deeper potential wells representing
strong interactions are assigned by geauxdock to salt bridges
between guanidinium groups in arginine residues and ligand
carboxyl moieties, compared to those less favorable, for example, between arginine and amide groups. Moreover, different types of hydrogen bounds have distinct geometries
and strengths. Although the mean interaction distance of hydrogen bond between the hydroxyl group on threonine and
ligand primary amine is shorter than that for the tyrosine hydroxyl and an amide group, the latter is slightly stronger at
the optimal distance. Also, force field parameters to model
hydrophobic interactions in geauxdock are in line with the
physicochemical properties of ligand atoms, for example,
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aromatic carbons and halogens tend toward non-polar residues, whereas amine nitrogen and carboxylate oxygen atoms
clearly prefer a polar microenvironment. Indubitably, these
carefully derived parameters are pivotal for the accuracy of
subsequent molecular modeling simulations. Other studies
systematically explore structural data in the PDB to calculate
distance-and angle-dependent statistical potentials for hydrogen bonds,[15] investigate the geometrical and energetic features of halogen bonds in biological molecules,[9,24] as well
as characterize hydrophobic and aromatic interactions at the
ligand–protein interface.[8,25]
Although π–π stacking, defined as an attractive, non-
covalent interaction between aromatic rings, is not as
widespread as hydrogen bonds and hydrophobic contacts,
it plays a vital role in biological recognition and the organization of biomolecular structures. The benzene dimer
is a prototypical system to study π–π aromatic stacking.
However, investigating this simple system poses significant practical challenges due to its relatively small binding
energy of about 2–3 kcal/mol and the fact that the dimer
is stable only at low temperatures. An experimental evidence of the perpendicular conformation in crystal and
liquid benzene was obtained by molecular beam electric
deflection study.[26] A subsequent theoretical research on
π–π interactions indicated that favorable perpendicular and
offset-parallel configurations correspond to energy minima of comparable depth, whereas the less stable eclipsed
geometry represents an energetic saddle point.[27,28]
Indeed, perpendicular and offset-parallel configurations
are dominant in the crystal structures of simple aromatic
compounds[29] and proteins,[30] in contrast to infrequently
observed eclipsed stacking.
As the major energetic contributors to π–π interactions
are London dispersion forces and electrostatics, many molecular force fields and scoring functions simulate aromatic
stacking implicitly with van der Waals and Coulomb potentials rather than employing explicit terms. On that account,
a systematic evaluation of the geometry of aromatic interactions in computer-generated models compared to that in
the experimental structures of organic ligand–protein complexes can cast light on the accuracy of the modeling of π–π
stacking in pharmaceutical design. In this communication,
we first conduct a large-scale statistical analysis or interfacial aromatic contacts in the crystal structures of organic
ligand–protein complexes employing a two-parameter geometric model. Our study considers various combinations of
aromatic protein residues and ring structures in ligand molecules. Subsequently, complex models constructed by contemporary docking software are carefully assessed in terms
of the predicted geometry of aromatic contacts. The results
have important ramifications for the development of molecular force fields and scoring functions for structure-based
drug discovery.
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Dataset of ligand–protein complexes

Aromatic rings in ligand molecules are identified with the
Chemistry::Ring::Find module available in PerlMol.1 This
module implements a breadth-first ring finding algorithm
to identify the Smallest Set of Smallest Rings.[31,32] Based
on atomic contacts detected with ligand–protein contact
(lpc) software,[33] we subsequently select those interactions
involving aromatic residues, phenylalanine (F), tyrosine
(Y), tryptophan (W) and histidine (H), and ligand aromatic
atoms. This procedure produces a complete list of interacting
aromatic rings in a given structure of a ligand–protein complex. Next, we employ a two-parameter model, presented in
Figure 1, to describe the geometry of each pair of interacting rings. The first parameter in this model is the Cartesian
distance between the geometric centers of two rings, referred
to as the distance. The second parameter is an angle between
normal vectors of two aromatic rings, referred to as the angle.
Further, the interaction type is specified using a notation
AP:L, where A is an amino acid, P is the number of amino
acid ring atoms, and L is the number of ligand ring atoms. For
instance, W6:5 denotes an interaction between a 6-member
benzene ring of tryptophan and a 5-member aromatic ring of
the ligand.

2.2

The protocol employed in this work to compile the dataset
of ligand–protein complexes is similar to that previously developed to generate representative and non-redundant sets of
ligand–protein complexes for benchmarking of eFindSite[34]
and other binding site prediction algorithms. First, we identified in the PDB protein chains composed of 50–999 amino
acids that non-covalently bind small organic molecules. Next,

F I G U R E 1 Two-parameter model describing the geometry of
aromatic interactions. Parameters are the Cartesian distance d between
the geometric centers of aromatic rings (blue) and an angle between the
normal vectors v1 and v2 of ring planes (red). Two distinct low-energy
configurations of the benzene dimer are shown, (a) perpendicular and
(b) parallel [Colour figure can be viewed at wileyonlinelibrary.com]
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we retained those proteins binding a single ligand whose
Tanimoto coefficient (TC) to at least one FDA-approved drug
is ≥0.5. The TC is calculated for 1,024-bit molecular fingerprints with openbabel[35] against FDA-
approved drugs in
[36]
the DrugBank database. Subsequently, protein sequences
were clustered with cd-hit[37] at 40% sequence similarity, and
a representative set of proteins binding chemically dissimilar ligands (a pairwise TC of <0.5) at different locations (at
least 8 Å apart) were selected from each homologous cluster.
Finally, we kept only those complexes stabilized by at least
one aromatic interaction between the ligand and the receptor
protein identified with lpc.[33] This procedure resulted in a
non-redundant and representative dataset of 3,079 proteins
bound to ligands containing aromatic moieties, referred to
as the daTaset tO evalUate alGoritHms for ligand Docking
(TOUGH-D1) dataset.

2.3

|

Molecular docking

In addition to experimental structures acquired from the
PDB,[18] a series of docking models were constructed for
TOUGH-
D1 complexes with two academic programs,
a
 utodock vina[38] and rdock.[39] vina has an excellent scoring
power according to a recent benchmarking study,[40] and it is
the most widely used molecular docking tool.[41] rdock is a
newly released program that is more accurate and faster than
other academic codes. For vina, mgl tools 1.5.6[42] and open
[43]
babel 2.4.1
were used to add polar hydrogens and partial charges, as well as to convert target proteins and library
compounds to the PDBQT format. The optimal search space
centered on the binding site was defined for each docking
ligand from its radius of gyration as described previously.[44]
Molecular docking was carried out by autodock vina 1.1.2
with the exhaustiveness parameter set to 1,000. For rdock,
[43]
open babel 2.4.1
was used to convert receptor proteins
and ligands to the required Tripos MOL2 and SDFile formats. The docking box was defined by the rcavity program
employing the reference ligand method. Simulations were
conducted by rdock 2013.1 with the default scoring function
and 100 docking runs per ligand. Finally, we executed vina
for each ligand–protein system with the –local_only option
to generate near-native conformations and the –randomize_
only option to generate 100 random configurations avoiding
atomic clashes.
Docking models constructed for TOUGH-D1 complexes
were evaluated with the Contact Mode Score (CMS)[45]
against experimental binding poses. The CMS is a new metric assessing the conformational similarity based on intermolecular ligand–protein contacts, which is less dependent
on the ligand size compared to the widely used root-mean-
square deviation. It ranges from about 0 for random binding
poses to 1 for identical configurations. Two sets of conformations were compiled from docking models generated by

|
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vina, a native-like set comprising those configurations having
a CMS of ≥0.5 and a random set of models whose CMS to
the experimental structure is <0.3. In addition, we prepared
a set of high-scoring models for each docking program based
on the predicted binding affinity.

|

2.4

Data analysis and visualization

Two-dimensional histograms of the distribution of geometric
parameters describing aromatic interactions, the distance and
the angle, were smoothed with the kernel density estimation
(KDE) technique.[46,47] KDE is a nonparametric method estimating the probability density function of a set of variables
based on a finite data sample. The parameter space was first
discretized to a 100 × 100 matrix and then populated with
observations, that is, distance and angle values computed
for each aromatic interaction in a given dataset. To smooth
the data with KDE, each observation was represented by a
Gaussian kernel, which is a non-negative function integrating
to 1 and with a mean of 0. matrix2png 1.2.2[48] was then used
to generate heat maps showing the correlative distribution of
geometric parameters for aromatic interactions. In addition
to the visual analysis of heat maps, the overlap between two
probability distributions is measured with the G test[49,50]:
( )
∑
Oi
G = 2 Oi × ln
(1)
i
Ei
where Oi and Ei are the observed and expected counts in the
ith cell and the sum is taken over all nonempty cells in the
100 × 100 matrix. Finally, pKa values are assigned to histidine residues with propka 3.1[51,52] and the molecular structures of ligand–protein complexes are visualized with visual
[53]
molecular dynamics 1.9.3.

3
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RESULTS

3.1 | Geometry of aromatic contacts in
experimental complex structures
The TOUGH-D1 dataset of experimental structures compiled in this study comprises 3,079 ligand–protein complexes
forming a total number of 8,148 interactions between 4,967
aromatic rings of organic ligands and 5,961 protein residues.
The amino acid composition of these interactions is 37.4%
F6, 23.5% Y6, 24.7% H5, 5.5% W5, and 8.9% W6. Further,
56.0% and 44.0% of aromatic interactions involve 6-and
5-member rings in ligand molecules, respectively, whose
atomic makeup is 75.2% carbon, 24.7% nitrogen, 0.1% sulfur,
and 0.03% oxygen. Table 1 shows the composition of aromatic interactions in TOUGH-D1 complexes. Phenylalanine,
tyrosine, and tryptophan residues form more interactions
with 6-member ligand rings, in contrast to histidine residues
that prefer to interact with 5-member ligand rings. Aromatic

|
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TABLE 1

Composition of aromatic interactions across the
TOUGH-D1 dataset
Ligand ring
6-member (%)

5-member (%)

6

21.8

15.6

6

Amino acid ring
F

Y

15.4

8.1

W5

3.4

2.1

6

5.8

3.1

9.6

15.1

W

H5

Interactions between phenylalanine (F6), tyrosine (Y6), tryptophan (W5 and W6)
and histidine (H5) residues, and 6-and 5-member ligand aromatic rings are
considered.

interactions involving a bicyclic side chain of tryptophan
more often are formed through its 6-member benzene ring
than a 5-member nitrogen-containing pyrrole ring.
Figure 2 shows the correlative distribution of distance and
angle values for all interaction types calculated for the experimental structures of ligand–protein complexes included in
the TOUGH-D1 dataset. The distance ranges from 3 to 8 Å,
and the angle is within the acute range of 0°–90°. In general,
most interactions have two distinct regions of a high probability density. The first recognizable geometry is described
by a relatively close distance of about 3.5–4.5 Å between the
centers of aromatic rings, and a small angle of 0°–15° between the normal vectors of ring planes. This range of parameters corresponds to a parallel aromatic stacking, shown
for the benzene dimer as a prototypical system in Figure 1b.
The second densely populated region described by longer
distances of 5–6 Å and near-right angles corresponds to a

perpendicular aromatic interaction, another typical geometry
illustrated for the benzene dimer in Figure 1a.
Distance and angle values obviously mutually depend on
one another, for example, rotating one aromatic ring by 90° in
order to change the parallel stacking to a perpendicular orientation pushes rings farther apart because of the van der Waals
repulsion between the clouds of ring atoms. Further, there
are certain differences between interactions involving various amino acids and ligand rings. For instance, the presence
of a hydroxyl group in tyrosine perceptibly changes the geometry of aromatic interactions with respect to phenylalanine.
Notably more intermediate configurations between parallel
and perpendicular regions can be observed for F6:6 (Figure 2a)
and F6:5 (Figure 2b) compared to Y6:6 (Figure 2c) and Y6:5
(Figure 2d). The 5-member aromatic ring in tryptophan favors
a parallel stacking with 6-member ligand rings (Figure 2e),
but forms both parallel and perpendicular interactions with
5-member ligand rings (Figure 2f). Because of the fused ring
structure of tryptophan side chains, W6:6 has a dual peak
within the perpendicular region (Figure 2g), and the majority of W6:5 interactions are parallel with a somewhat broader
range of distances between rings of 3–5.5 Å (Figure 2h).
Finally, histidine residues form both parallel and perpendicular interactions with 6-member ligand rings (Figure 2i),
whereas perpendicular geometries are the most common for
those interactions involving 5-member ligand rings (Figure 2j).
Depending on the pH, a histidine switches between the double-
protonated form with both δ and ε nitrogen atoms protonated,
and the neutral state with either δ or ε nitrogen protonated. On
that account, in Figure 3, we show the distribution of geometrical parameters for H5:6 and H5:5 interactions in two groups
identified based on the predicted pKa shift from the model value

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

F I G U R E 2 Heat maps showing the
distribution of the geometrical properties
of aromatic interactions across the
experimental structures of ligand–protein
complexes included in the TOUGH-D1
dataset. The interaction geometry is
described by two parameters, an angle
between the normal vectors of aromatic
rings and a distance between ring centers.
The following interaction types are
presented: (a) F6:6, (b) F6:5, (c) Y6:6, (d)
Y6:5, (e) W5:6, (f) W5:5, (g) W6:6, (h) W6:5,
(i) H5:6, and (j) H5:5 [Colour figure can be
viewed at wileyonlinelibrary.com]
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of 6.5 for the imidazole side chain. According to propka3,[51,52]
as many as 84.6% of histidines interacting with ligand aromatic
rings are acidic with negative pKa shifts from the model value,
most likely because the protonation of histidine residues has
a stabilizing effect of about 1–3 kcal/mol.[17,54] Consequently,
interaction geometries shown in Figure 2i,j are biased toward
protonated histidine residues, for which the distributions of
distance and angle values are also independently presented
in Figure 3a,b. Interestingly, the protonation of the imidazole
side chain has a notable effect on the geometry of aromatic
interactions. The vast majority of H5:5 interactions involving
protonated histidine residues are perpendicular, likely due to
the additional favorable contribution from the cation–π electrostatic energy.[17] In contrast, the distributions of geometrical
properties of π–π interactions involving neutral histidine residues shown in Figure 3c,d are qualitatively similar to those
computed for other aromatic amino acids.

3.2 | Examples of aromatic interactions
stabilizing ligand–protein complexes
We selected a series of representative examples to examine the molecular structures of aromatic interactions in the

(a)

(b)

(c)

(d)

F I G U R E 3 Heat maps showing the distribution of the
geometrical properties of aromatic interactions involving histidine
residues across the experimental structures of TOUGH-D1 complexes.
The interaction geometry is described by two parameters, an
angle between the normal vectors of aromatic rings and a distance
between ring centers. Interactions are divided into two groups with
(a, b) negative and (c, d) positive shifts from the model pKa value
for the imidazole side chain. The following interaction types are
presented: (a, c) H5:6 and (b, d) H5:5 [Colour figure can be viewed at
wileyonlinelibrary.com]
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context of high probability density regions in heat maps presented in Figure 2. Figure 4 shows four ligand–protein complexes stabilized by various aromatic contacts. Predominant
interactions are exemplified by those formed by pyridoxal-
5′-phosphate and phenylalanine residues. The offset-parallel
aromatic stacking in glutamine aminotransferase from
Thermus thermophilus HB8 (Figure 4a, PDB-ID: 1v2d, chain
A)[55] has a distance of 3.8 Å and an angle of 8.5°, whereas the
perpendicular stacking in maize serine racemase (Figure 4b,
PDB-ID: 5cvc, chain B)[56] has a distance of 4.9 Å and an
angle of 79.5°. Further, complexes shown in Figure 4c,d
typify interactions between nucleotides and tyrosine residues. The offset-parallel aromatic stacking between ADP and
Y474 in isocitrate dehydrogenase kinase/phosphatase from
Escherichia coli (Figure 4c, PDB-ID: 3lc6, chain A)[57] consists of two interactions, Y6:5 and Y6:6. The former involves
a 5-member ring a1 and has a distance (angle) of 4.0 Å (7.4°),
and the latter involves a 6-member ring a2 and has a distance
(angle) of 4.0 Å (6.3°). ATP bound to Hmd co-occurring protein HcgE from Methanothermobacter marburgensis forms
two perpendicular interactions with Y91 (Figure 4d, PDB-ID:
3wv8, chain B).[58] In this complex structure, Y6:5 (ring a1)
has a distance of 5.1 Å and an angle of 76.9°, whereas Y6:6
(ring a2) has a distance of 5.1 Å and an angle of 77.2°.
Figure 5 presents three examples of ligand–protein complexes stabilized by multiple aromatic interactions involving tryptophan and histidine residues. Proflavin forms a
3-layer parallel stacking with two tryptophan residues, W95
and W126, when bound to multidrug binding protein EbrR
from Streptomyces lividans (Figure 5a, PDB-ID: 3hth, chain
A). For example, the middle ring a2 in proflavin forms two
offset-parallel interactions with W95, W5:6 with a distance
(angle) of 4.6 Å (4.2°) and W6:6 with a distance (angle) of
3.7 Å (4.1°), as well as a near-parallel interaction with W126,
W5:6 whose distance (angle) is 5.9 Å (36.5°). In addition,
the EbrR/proflavin complex is stabilized by aromatic interactions with F67 and Y107; for instance, proflavin interacts
with F67 through a perpendicular stacking F6:6 with a distance (angle) of 5.2 Å (83.9°). A series of perpendicular aromatic interactions are formed between tryptophan residues
W47 and W52 of the human catalytic elimination antibody
13G5 and a hapten molecule (Figure 5b, PDB-ID: 3fo2, chain
B).[59] Distance (angle) values for selected contacts involving W47, W5:5, W6:6, and W5:6 are 5.7 Å (85.1°), 6.3 Å
(85.6°), and 6.1 Å (85.6°), respectively. Also, histidine H98
perpendicularly interacts with the ring a1 of the ligand with
a distance of 4.8 Å and an angle of 75.1°. The last example
is metallo-β-lactamase from Bacteroides fragilis bound to a
potent inhibitor (Figure 5c, PDB-ID: 1a8t, chain A).[60] This
complex is stabilized by a variety of aromatic interactions
involving three histidine residues, H84, H145, and H206, as
well as tryptophan W32. For instance, H206 forms a parallel
stacking H5:6 against ring a3 with a distance (angle) of 5.6 Å

386
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(b)

F I G U R E 4 Examples of aromatic
stacking in ligand–protein complexes
involving phenylalanine and tyrosine
residues. (a, b) pyridoxal-5′-phosphate and
phenylalanine residues, and (c, d) ADP/ATP
and tyrosine residues. Two distinct stacking
geometries are presented: (a, c) offset-
parallel and (b, d) perpendicular. Ligands
are colored by atom type (C—green, N—
blue, O—red, P—ocher), whereas aromatic
binding residues are purple. Normal vectors
of aromatic rings are shown as yellow
sticks [Colour figure can be viewed at
wileyonlinelibrary.com]

(d)

(22.0°), and a perpendicular interaction H5:5 against ring a1
with a distance (angle) of 4.0 Å (72.0°). Furthermore, both
rings of W32 make parallel contacts with ring a3 of the inhibitor whose distances (angles) are 5.7 Å (11.8°) for W5:6 and
5.5 Å (11.4°) for W6:6.

3.3 | Aromatic contacts in computer-
generated complex structures
Heat maps presented in Figure 2 clearly demonstrate that
aromatic interactions in the experimental structures of ligand–protein complexes tend to adopt certain geometries.
An important question from a modeling point of view is
whether similar stacking configurations are observed in the
theoretical models of complex structures generated by molecular docking. To look into this facet of ligand docking,
we analyze aromatic interactions in four sets of theoretical
models of ligand–protein assemblies constructed for the
TOUGH-D1 dataset. In addition to heat maps presented in
Figure 6, the deviation from the reference probability distribution obtained for experimental structures is quantified by
the G test. G-values are reported in Table 2 for all interaction
types with smaller values indicating a better agreement with
the reference distribution. Heat maps generated for native-
like configurations (1st column in Figure 6) are very similar to those shown in Figure 2 for experimental structures.
Further, the average G-value for this set is as low as 0.184.
This can be expected because employing a CMS threshold
of ≥0.5 ensures that the modeled ligand–protein contacts are
highly correlated with those in experimental structures.
vina and rdock construct ligand conformations in which
the geometry of aromatic interaction does not deviate far away
from that in experimental complexes (2nd and 3rd columns
in Figure 6). Although the average G-values for both docking tools are comparable, there are notable differences with

respect to individual interaction types. In general, binding
poses generated by vina have better geometries of aromatic
interactions involving 6-member rings in ligand molecules
than rdock. For instance, G-values for F6:6, Y6:6, W5:6, and
H5:6 modeled by vina are 0.122, 0.118, 0.359, and 0.312, respectively, compared to 0.179, 0.165, 0.753, and 0.340 for
rdock. However, rdock seems to model certain interactions
involving 5-member rings more accurately than vina; for example, G-value for W5:5 (H5:5) is 0.581 (0.278) for rdock
and 1.065 (0.601) for vina. The quality of other interaction
types, such as F6:5, Y6:5, W6:6, and H5:6, in docking models
is to a large extent independent of the docking algorithm. For
comparison, the last column in Figure 6 shows the distribution of distance and angle values across a dataset of random
ligand–protein configurations. The correlative distribution
of geometric parameters for aromatic interactions is totally
lost when ligands are arbitrarily positioned within their target binding sites only to avoid steric clashes. In addition,
G-values for random conformations reported in Table 2 are
much higher than those calculated for high-scoring models
by vina and rdock; for example, the average G-value across
the random dataset is as high as 2.185, compared to only
0.401 for vina and 0.399 for rdock.
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DISCUSSION

In this communication, we report the results of a statistical analysis of aromatic contacts at the ligand–protein
interface. A two-parameter model considering a distance
between the geometric centers of aromatic rings and an
angle between normal vectors of ring planes is employed
to investigate interfacial π–π interactions in experimental as well as computer-
generated complex structures.
Our analysis of X-ray crystallography data is consistent

BRYLINSKI

F I G U R E 5 Examples of aromatic stacking in ligand–protein
complexes involving tryptophan and histidine residues. (a) EbrR
complexed with proflavin, (b) catalytic antibody 13G5 complexed
with a hapten, and (c) metallo-β-lactamase complexed with a biphenyl
tetrazole inhibitor. Ligands are colored by atom type (C—green, N—
blue, O—red), whereas aromatic binding residues are purple. Normal
vectors of aromatic rings are shown as yellow sticks [Colour figure can
be viewed at wileyonlinelibrary.com]

with the geometrical and energetic properties of aromatic
stacking reported previously. Exploring the potential energy surface for the benzene dimer with ab initio methods
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revealed two nearly isoenergetic structures, perpendicular
and offset-
parallel configurations.[61] The ideal offset-
parallel conformation with an angle between ring planes of
0° has the lowest energy of −3.33 kcal/mol at a horizontal
displacement of 1.54 Å, whereas perfectly perpendicular
structures with an angle of 90° have interaction energies
of −2.84 kcal/mol (point-face) and −2.51 kcal/mol (edge-
face).[27] Another QM study predicted that perpendicular
and offset-parallel configurations are nearly isoenergetic
with binding energies of 2.7 and 2.8 kcal/mol, respectively.
These two low-energy arrangements of aromatic rings appear as distinct areas of high probability density on the
distance-angle maps constructed in this study for different
combinations of protein aromatic residues and ligand ring
structures present in the TOUGH-D1 dataset.
With respect to the geometry of π–π interactions, a distance of 4.96 Å between the centers of mass of individual
rings in the perpendicular benzene dimer in the gas phase
was measured by rotational experiments.[62] Similar distances
of 5.0–5.1 Å were obtained with QM calculations.[27,28,61,63]
These values match a lower bound of the intermonomer
distance range in ligand–protein complexes, which in our
analysis extends to about 6 Å. This broader distance range
is likely caused by divers chemical moieties attached to aromatic rings in ligand molecules. It has been reported that
adding a substituent to one of the rings in the benzene dimer
impacts the π–π interaction energy and geometry compared
to unsubstituted systems.[64] Specifically, Monte Carlo simulations demonstrated that the presence of a substituent tends
to increase the intermonomer separation in perpendicular
conformations. For instance, the lowest energy structure of
the benzene/phenol dimer has a distance of 5.6 Å, which increases to 6.2 Å as the dimer adopts an edge-to-edge configuration. Furthermore, ab initio calculations together with
the analysis of X-ray crystallography data showed that aromatic molecules form stacks with the vertical separation of
3.3–4.1 Å between ring planes in various parallel orientations,[27–29] closely matching the distance range for the parallel aromatic stacking in our analysis. Interestingly, a quantum
chemistry study of the benzene dimer revealed the presence
of a shallow minimum on the path interconverting offset-
parallel structures through a perpendicular saddle point.[27]
This configuration corresponds to a tilt angle between phenyl
ring planes of about 45°, which can also be observed as a medium probability density area at a distance of approximately
5.5 Å in our distance-angle maps generated for phenylalanine
and tyrosine residues.
Previous studies investigating aromatic stacking at the ligand–protein interface are often focused only on nucleotide
binding; for instance, it was reported that 65% of adenylate-
protein complexes form π–π interactions between adenine
bases and aromatic side chains with two predominant orientations, offset-parallel and perpendicular.[65] A similar model
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FIGURE 6

Heat maps showing the distribution of the geometrical properties of aromatic interactions across the computer-generated models
of ligand–protein complexes included in the TOUGH-D1 dataset. The interaction geometry is described by two parameters, an angle between the
normal vectors of aromatic rings and a distance between ring centers. The following interaction types are presented: (a) F6:6, (b) F6:5, (c) Y6:6, (d)
Y6:5, (e) W5:6, (f) W5:5, (g) W6:6, (h) W6:5, (i) H5:6, and (j) H5:5. Four models are considered for each interaction type: native-like conformations,
high-scoring models reported by vina and rdock, and ligands randomly positioned within binding sites [Colour figure can be viewed at
wileyonlinelibrary.com]

to that used in the present study was employed to survey the
structures of complexes between proteins and adenine-and
guanine-containing ligands in the PDB.[4] Reported values of
the vertical distance between ring planes of less than 4.5 Å
for parallel and less than 5.5 Å for perpendicular orientations
are in line with our analysis of the X-ray crystallography
data. Nonetheless, a somewhat broader range of distances observed for the perpendicular configurations in our distance-
angle maps arise from the fact that geometric parameters
describing aromatic stacking in ligand–protein complexes are
derived in the present study from a more diverse collection of
compounds containing aromatic groups.
In addition to the experimental structures of ligand–protein complexes, we examine the geometry of aromatic interactions in theoretical models constructed by molecular docking.
To the best of our knowledge, scoring functions implemented
in modern docking programs treat π–π stacking as van der
Waals and Coulombic interactions. This description of aromatic interactions is sufficient in some cases. For instance,
docking of a series of agonists to the binding pocket of the
homology model of the serotonin 5-HT2C G protein-coupled

TABLE 2

Deviation of the geometry of aromatic interactions
from experimental structures for computer-generated models of
TOUGH-D1 complexes
Protein–ligand conformations
Interaction
6

F :6

Native-like
0.045

vina

0.122

rdock

0.179

Random
1.622

6

F :5

0.113

0.199

0.203

2.198

Y6:6

0.082

0.118

0.165

1.733

Y6:5

0.132

0.333

0.354

2.232

W5:6

0.274

0.359

0.753

2.325

5

W :5

0.296

1.065

0.581

3.479

6

W :6

0.131

0.274

0.271

1.585

W6:5

0.418

0.628

0.862

3.049

5

H :6

0.130

0.312

0.340

1.530

H5:5

0.215

0.601

0.278

2.093

Average

0.184

0.401

0.399

2.185

The deviation is measured with the G test for native-like conformations, high-
scoring models constructed by vina and rdock, and ligands randomly positioned
within binding sites.
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receptor with the PatchDock server[66] produced ligand conformations interacting with tryptophan and phenylalanine
residues through parallel and perpendicular aromatic stacking.[67] Another example is a molecular modeling study conducted with Glide[68] for subnanomolar affinity antagonists
of the cannabinoid receptor CB2.[69] Docking calculations revealed a number of parallel and perpendicular aromatic contacts between chloromethylphenyl and methylbenzyl rings
of the compounds and a cluster of aromatic residues in CB2,
suggesting that π–π interactions are critical to the efficacy of
these antagonists.
Postprocessing of docking models is a common practice to
improve the prediction accuracy of molecular docking. For instance, molecular mechanics with continuum solvation offers
a rigorous approach to decompose free energy into individual
contributions from various interaction groups enhancing the
screening and ranking power of autodock.[70,71] In addition,
it has been reported that re-ranking guanosine triphosphate
(GTP) docking poses generated by the gold[72] program by
explicitly accounting for the π–π stacking yields a higher accuracy of the modeling of GTP–protein complexes compared
to the default goldscore scoring function.[4] Our assessment of
docking models constructed by autodock vina[38] and rdock[39]
for a diverse collection of ligands and proteins included in the
TOUGH-D1 dataset indicates that although state-of-the-art
molecular docking force fields provide sufficient specificity to
reliably model aromatic interactions, the geometry of π–π contacts in high-scoring conformations could still be improved.
The comprehensive analysis of aromatic geometries at ligand–
protein interfaces presented in this study lies the foundation
for the development of type-specific statistical potentials to
more accurately treat π–π interactions in molecular docking.
A Perl script to detect and calculate the geometric parameters of aromatic interactions in ligand–protein complexes is
available at https://github.com/michal-brylinski/earomatic.
The TOUGH-D1 dataset comprising experimental structures
and computer-generated models of ligand–protein complexes
is available at https://osf.io/rztha/.
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